Drug Approval Package

 BuSpar (Buspirone Hydrochloride) Capsules
Company:  Bristol-Myers Squibb Co.
Application No.:  021190
Approval Date: 12/20/2000

• Approval Letter(s) (PDF)

• Printed Labeling (PDF)

• Medical Review(s) (PDF)  

• Chemistry Review(s) (PDF)

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)

• Administrative Document(s) (PDF)

Date created: March 112004

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.